Table 4. Influence of Substitution Therapy on the Level of Adherence to Treatment.
Methadone/Buprenorphine Therapy (n = 27) | No Substitution Therapy (n = 67) | P value b | |
SVR (ITT analysis a), No. (%) | 15 (55.55) | 50 (74.62) | 0.0866 |
SVR genotype 1 and 4 | 5 (38.46) | 32 (72.72) | 0.0442 |
SVR genotype 2 and 3 | 10 (71.42) | 18 (78.26) | 0.7046 |
Lost of follow-up, No. (%) | 7 (25,92) | 7 (10.44) | 0.1050 |
Treatment completion rate, No. (%) | 27 (100) | 64 (95.52) c | 0.5546 |
a Abbreviation: ITT, intention-to-treat analysis
b Fisher's exact test
c In three patients treatment was discontinued